Recombinant NDV Vectored Vaccine (Laboratorio Avi-Mex)

N/A

Report date: 2023/04/02 18:03:20

Base Information

Drug NameRecombinant NDV Vectored Vaccine (Laboratorio Avi-Mex)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorio Avi-Mex, SA de CV
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios SaLaboratorio Avi-Mex, SA de CV
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A